Evidence map›Paper›PMID 8795582›Full record

ArticleBritish journal of cancer1996

Tyrosine phosphorylation of 100-130 kDa proteins in lung cancer correlates with poor prognosis.

M Nishimura, K Machida, M Imaizumi, T Abe, T Umeda, E Takeshima, T Watanabe, Y Ohnishi, K Takagi, M Hamaguchi

Open access · bronzeAbstract read
In one paragraph

Article in British journal of cancer, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. The prognostic significance of focal adhesion kinase expression in stage I non-small-cell lung cancer.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2014
    Article
  5. Focal adhesion kinase as a cancer therapy target.Anti-cancer agents in medicinal chemistry · 2010
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

M NishimuraDepartment of Thoracic Surgery, Nagoya University School of Medicine, Japan.
K Machida
M Imaizumi
T Abe
T Umeda
E Takeshima
T Watanabe
Y Ohnishi
K Takagi
M Hamaguchi
Nagoya University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To search for the signalling pathways in lung cancer relevant to its aggressive behaviour, we studied tyrosine phosphorylated proteins in lung cancer cell lines and surgical specimens. We found that the profiles of protein phosphorylation were closely matched among these cell lines and cancer tissues of different histological origins, and 100-130 kDa proteins were the major components of phosphorylated proteins. In surgical specimens, approximately half of the cases showed tyrosine phosphorylation of these proteins in a tumour-specific manner, and phosphorylation of these proteins showed good correlation with the survival length of patients after operation. By immunoprecipitation with specific antibodies, we found that p125FAK, p120 and beta-catenin were the major components of tyrosine-phosphorylated proteins in the surgical specimens. These results suggest that tyrosine phosphorylation of these proteins may play a role in tumour relapse and is available as a clinical marker.

Indexed as

AgedCarcinoma, Non-Small-Cell LungCarcinoma, Small CellCarcinoma, Squamous CellCell Adhesion MoleculesDisease-Free SurvivalFemaleFocal Adhesion Kinase 1Focal Adhesion Protein-Tyrosine KinasesHumansImmunoblottingLung NeoplasmsMaleMiddle AgedNeoplasm ProteinsPhosphoproteinsCell Adhesion MoleculesFocal Adhesion Kinase 1Focal Adhesion Protein-Tyrosine KinasesNeoplasm ProteinsPhosphoproteinsProtein-Tyrosine KinasesPTK2 protein, human

Identifiers

PMID8795582
PMCPMC2074703
OpenAlexW2028683833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.